Johnson & Johnson - Latest News and Information
JNJ
Johnson & Johnson is a global healthcare company focused on medicines, medical devices, and consumer health products. The company operates in therapeutics including oncology, immunology, neuroscience, and cardiopulmonary areas, and develops innovative medical technologies across cardiovascular, orthopaedics, surgery, and vision. Through its Innovative Medicine and MedTech divisions, J&J aims to address complex diseases with science-driven approaches and patient-centered care worldwide. Headquartered with a strong presence in multiple regions, the company emphasizes scientific advancement, patient outcomes, and global health impact.
Hologic CEO Steve MacMillan to Retire After Go-Private Deal
Diagonal Banks Another $125M for ‘Clustering’ Antibody Drugs
AbbVie, Amgen, Lilly Lead Calls for FDA To Update Post-Approval Change Rules
Dizal Breaks New Ground for EGFR Drugs in Lung Cancer
Parabilis Heads Biotech Fundraising Frenzy With $305M to Advance Cancer Drug
Hawkesbury Conducts Surgery with J&J Robot
FDA Sets Feb. 1 Launch Date for PreCheck Pilot To Strengthen Domestic Supply Chain
Ocugen Shares Fall, Despite Positive Eye Disorder Trial
JPM26: Protagonist Has a $400M Decision To Make. It’s a No-Brainer
Ghent, Porto, Wroclaw: Future European HealthTech and MedTech Hubs
PharmaShots Quarterly Outlook: The Forces Reshaping Biopharma in Q1 2026
Johnson & Johnson Brushes Off MFN Impact, Sees Strong Growth for 2026
Top 10 Most Popular Drug Hunter Reviews of 2025
TCT Asia 2026 Now Returns to Shanghai Bigger Than Ever
Defensive ETFs Surge as VIX Jumps 73% Amid Early 2026 Turmoil
JPM26: Filling C-Suites, Union Square—And Elevators—With Pink
Gepotidacin
Bristol Myers Squibb and Johnson & Johnson Launch Educational Program for Thromboembolic R&D
Medtronic Completes First Hugo Case in the US
Proteasomes: A Novel Approach to Target the Immune System
CMS's Medicare Price Negotiations Start Round Three
Opinion: Pricing Transparency Is Coming to the Pharma Industry
Six Biotech Companies Advancing the Next Generation of Prostate Cancer Therapies
Pinnacle Medicines Adds $89M for Oral Peptides With Properties of Injectable Biologics
FDA Delays Decision for Lilly’s Obesity Pill Orforglipron, Other Priority Voucher Awardees: Report
J&J Reports Positive Phase 3 Data for Tecvayli in Earlier Blood Cancer Setting
2 Stocks I Plan to Hold for the Next 20 Years
9 Companies Hiring Now in Pennsylvania
Court Largely Grants Class Certification, But Narrows Walker Process Claims over Biologic Drug Stelara on Summary Judgment
ImmunityBio Rises as Route Opens to Broader Anktiva Label
J&J’s Darzalex Faspro Notches Another Multiple Myeloma Indication, Pushing Into Frontline
J&J Bets on Isomorphic for AI-Powered Drug Hunt
Organizational Structure for Companies With Examples and Benefits
Zanubrutinib Demonstrates Favorable Tolerability in R/R CLL/SLL
Charlotte Emerging as a Global Leader in Health Care Innovation and Med Tech
Is Intuitive Surgical, Inc. (ISRG) A Good Stock To Buy Now?
Stocks Recover as Oil Retreats From $119: Stock Market Today
DRIP Investment: How Dividend Reinvestment Plans Boost Your Portfolio
TCTMD’s Top 10 Most Popular Stories for March 2026
Stagflation Fears Are Back: These 3 Stocks Can Help You Ride Out the Storm
11 Companies Hiring Manufacturing Professionals Now
J&J Strikes Drug Pricing, Tariff Deal with the White House
GlobalData’s Key Thoughts From World EPA Congress 2026
Gene Therapy Reduces Geographic Atrophy Lesion Growth
The New Gold Rush in Brain Science
Biopharma Catalysts in Q2 2026 Signal High-Profile Approval Decisions and Rising Competition
Johnson & Johnson’s Hematology Portfolio: Breakthroughs to Watch
12 Most Profitable Blue Chip Stocks to Invest In Now
J&J Builds Case for Earlier Tecvayli Use in Multiple Myeloma
LAA Closure Superior to Anticoagulation for Bleeding in AF
No recent deals for this company.
